With the increased number of channels available to reach healthcare professionals alongside dramatically fewer in-person opportunities due to institutional restrictions, pharma marketers are facing more challenges than ever before to break through the noise. The traditional sales pitches and mass emails are a thing of the past with the growing need to create a personalized digital strategy to reach healthcare providers.
Real Chemistry, a leading provider of data-driven, tech-enabled communication and marketing solutions for the healthcare sector, announced that Andy Johnson has joined the company as Chief Information Officer (CIO). Johnson’s primary responsibilities will be to drive Real Chemistry’s information strategy, strengthen organizational systems and processes to best support the company’s people and clients, and innovate new ways to connect and collaborate.
Biogen Inc. on Feb. 3 forecast 2022 profit well below Wall Street estimates as sales of the company’s new Alzheimer’s disease drug stall amid questions over Aduhelm’s efficacy and a looming U.S. government coverage decision that could severely limit the medicine’s future use and force further cost cutting.
Roche said ongoing trials of the company’s Alzheimer’s disease drug candidate gantenerumab are designed to provide unequivocal results on efficacy as controversy continues in the United States over the benefits of a rival’s approved drug.
AbbVie reported the company’s fourth-quarter 2021 and full-year financial results on Feb. 2, with worldwide net reviews up 7.4% to $14.89 billion for the quarter. Total revenues for 2021 were $56 billion. The company’s anchor product remains Humira, which will begin to lose exclusivity in 2023.
Aside from vaccines, the advent of several effective COVID-19 antiviral therapies, including Pfizer’s Paxlovid, provides hope for ending the pandemic. Details about the U.S. government’s contract with Pfizer for 10 million doses of Paxlovid are emerging, with some unusual elements.
Omnicom Health Group, the largest healthcare marketing and communications group in the world and part of Omnicom Group Inc., announced the acquisition of Propeller, a digitally focused omnichannel engagement marketing agency that specializes in healthcare.
U.S. regulators are considering the first COVID-19 vaccine for children under the age of 5, the only age group not yet eligible for the shots, after Pfizer Inc. and BioNTech SE began the regulatory approval process on Feb. 1.
New York-based Anavex Life Sciences announced positive topline results from the company’s Phase III AVATAR trial of Anavex 2-73 (blarcamesione) in adult female patients with Rett syndrome.
The emerging BA.2 form of the Omicron coronavirus variant does not seem to be any more severe than the original BA.1 form, an official of the World Health Organization said on Feb. 1.
